Eli Lilly’s Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts Proactive Investors (US) 21:06 Tue, 21 Apr
Solvonis Therapeutics results marked a successful strategic repositioning and pipeline expansion Proactive Investors (UK) 2d Biotechnology
Saudia Cargo and Sfda announce major air freight support initiative for pharmaceutical shipments Payload Asia 5h Saudi Arabia Air Cargo Middle East
Taoiseach hails new AstraZeneca facility in Dublin as 'significant vote of confidence' in Ireland The Irish Post 19h Rep. of Ireland AstraZeneca Dublin
Eli Lilly capitalizes on consumers' 'Love affair' with weight loss drugs: Gary black says valuation 'Still looks compelling' Benzinga 3d Mounjaro Pharma Article paywall All sources
Eli Lilly bets on recombinases in $2.25bn Profluent R&D pact Pharmaceutical Technology 5d Profluent CRISPR/Gene Editing Pharma All sources
Eli Lilly outlays $2.3bn to acquire blood cancer specialist Ajax Therapeutics Pharmaceutical Technology 7d Ajax Therapeutics Cancer Pharma All sources
GLP-1 pill race heats up as Wegovy tablet holds strong against Lilly rival Proactive Investors (US) 7d Novo Nordisk Ozempic Pharma All sources
How Promatix is ‘expanding the universe’ of targets for new cancer drugs Cambridge Independent 3d Cancer Biotech Cancer Treatment
Stealth biotherapeutics provides commercial launch update and pipeline progress across mitochondrial disease portfolio PR Newswire (Press Release) 4d Biotech
Ecolab Life Sciences opens bioprocessing applications lab in Korea to support downstream process development across Asia Manufacturing Chemist 4d Pharma Biotech
Infinimmune appoints Anthony slavin, pH.D., as Senior Vice President of Portfolio Strategy Business Wire (Press Release) 7d Biotech
Scientists redesign CAR-T cells to fight more than cancer News-Medical.Net 5d T-Cells Cancer Treatment Cancer All sources
Single-cell sequencing reveals why some CAR-T therapies succeed while others fail News-Medical.Net 4d T-Cells Genetics Biology
Curocell’s Rimqarto approval turns Korea’s CAR-T race into a reimbursement battle Korea Biomedical Review 4d World Conflicts Cancer Treatment Blood Cancer
GC Cell showcases CDMO capabilities at BIO KOREA 2026 Korea Biomedical Review 2h Pharma Biotechnology South Korea
New first-in-class therapy for chronic graft-versus-host disease approved in Australia[1] PR Newswire (Press Release) 17h Biotechnology South Pacific
Belgian biopharma company UCB to acquire US biotech company for 2 billion USD Belga News Agency 3h Pharma Biotechnology
Biotech M&A is accelerating. Track the deals that are happening here. BioPharma Dive 13h Pharma Biotechnology
